Norris Medicines Limited (BOM:524414)
India
· Delayed Price · Currency is INR 17.25
+0.17 (1.00%)
At close: Jul 7, 2025
Norris Medicines Revenue
In the fiscal year ending March 31, 2025, Norris Medicines had annual revenue of 58.20M INR with 3.28% growth. Norris Medicines had revenue of 27.21M in the quarter ending March 31, 2025, with 82.90% growth.
Revenue
58.20M
Revenue Growth
+3.28%
P/S Ratio
3.09
Revenue / Employee
1.29M
Employees
45
Market Cap
179.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 58.20M | 1.85M | 3.28% |
| Mar 31, 2024 | 56.36M | -27.23M | -32.58% |
| Mar 31, 2023 | 83.59M | -10.80M | -11.44% |
| Mar 31, 2022 | 94.38M | -28.13M | -22.96% |
| Mar 31, 2021 | 122.51M | 44.07M | 56.19% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |